Skip to main content

Press Releases

January 8, 2019

Washington, DCThe U.S. House of Representatives today approved legislation aimed at improving and speeding up the federal Food and Drug Administration's process for evaluating new over-the-counter (OTC) medications to determine whether they are safe enough to be sold to consumers without a prescription.

December 21, 2018

Washington, DC – Rep. Diana DeGette released the following statement after funding expired for nine federal departments and numerous agencies:

"Families in Colorado and across America should be enjoying the holiday season with their loved ones. Instead, this shutdown is forcing many to worry about their livelihoods during what should be a relaxing and celebratory time of year.

December 18, 2018

Washington, DC – Rep. Diana DeGette (CO-01) led 68 of her fellow House Democrats in submitting technical comments opposing an Environmental Protection Agency (EPA) proposal to weaken emissions standards for methane and other compounds.

December 13, 2018

Washington, DC -- Representatives. Diana DeGette (D-CO) and Fred Upton (R-MI) today released the following statement on the second anniversary of the 21st Century Cures Act being signed into law by President Barack Obama:

"21st Century Cures began with the spark of hope and continues today – pushing medical research in new and innovative ways.

December 13, 2018

Washington, DC – Today, Representatives Diana DeGette (CO-01) and Ed Perlmutter (CO-07) along with Colorado Senators Michael Bennet (D-CO) and Cory Gardner (R-CO) sent a letter to the Federal Railroad Administration (FRA), Denver Regional Transportation District (RTD), and Denver Transit Partners (DTP) urging continued cooperation in finalizing a plan of action to fix ongoing issues with grade

December 11, 2018

Washington, D.C.U.S. Representatives Diana DeGette's (D-CO) and Jaime Herrera Beutler's (R-WA) bipartisan bill to prevent maternal deaths passed the U.S. House by unanimous voice vote today.

December 11, 2018

Washington, DC -- Congressional Diabetes Caucus co-chairs Reps. Diana DeGette (D-CO) and Tom Reed (R-NY) issued the following statement after the FDA finalized guidance treating insulin as a biologic product:

December 10, 2018

Washington, DC – U.S. Senator Michael Bennet (D-CO) today led Colorado U.S. Representatives Diana DeGette, Ed Perlmutter, and Jared Polis, and Representatives-elect Joe Neguse and Jason Crow, in sending a letter to the Department of Homeland Security to object to the proposed rule expanding the definition of "public charge" under U.S. immigration law.

December 6, 2018

Washington, DC— Congresswoman Diana DeGette (D-CO), a senior member of the Energy and Commerce Committee, joined fellow committee member, Congressman Larry Bucshon, M.D. (R-IN), and U.S.

December 6, 2018

Washington, DC – Oversight and Investigations Ranking Member Diana DeGette (D-CO) joined fellow Democratic leaders on the Energy and Commerce Committee, Ranking Member Frank Pallone, Jr.